T. Rowe Price Associates’s Wright Medical Group, Inc. Contingent Value Right WMGIZ Stock Holding History

T. Rowe Price Associates’s Portfolio WMGIZ Stock Details WMGIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-132,507	Closed	-$191K	–	2614
2018 Q3	$191K	Hold	132,507	–	–	﹤0.01%	2467
2018 Q2	$182K	Hold	132,507	–	–	﹤0.01%	2472
2018 Q1	$176K	Hold	132,507	–	–	﹤0.01%	2439
2017 Q4	$200K	Hold	132,507	–	–	﹤0.01%	2425
2017 Q3	$208K	Hold	132,507	–	–	﹤0.01%	2402
2017 Q2	$201K	Hold	132,507	–	–	﹤0.01%	2385
2017 Q1	$203K	Hold	132,507	–	–	﹤0.01%	2394
2016 Q4	$175K	Hold	132,507	–	–	﹤0.01%	2407
2016 Q3	$172K	Hold	132,507	–	–	﹤0.01%	2371
2016 Q2	$166K	Hold	132,507	–	–	﹤0.01%	2367
2016 Q1	$163K	Hold	132,507	–	–	﹤0.01%	2333
2015 Q4	$135K	Buy	+132,507	New	+$135K	﹤0.01%	2377

Other funds holding WMGIZ

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

T. Rowe Price Associates's WMGIZ Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Wright Medical Group, Inc. Contingent Value Right (WMGIZ) in Q4 2018, closing a stake of 132,507 shares — an estimated $191K sold.

T. Rowe Price Associates first reported a position in WMGIZ in Q4 2015 and held it in 12 quarters. The position peaked at $208K in Q3 2017. 19 funds tracked by Wall St. Rank hold WMGIZ as of Q4 2018.

T. Rowe Price Associates reported no remaining Wright Medical Group, Inc. Contingent Value Right position as of Q4 2018 after selling out during the quarter.
T. Rowe Price Associates sold 132,507 Wright Medical Group, Inc. Contingent Value Right shares in Q4 2018, an estimated $191K.
T. Rowe Price Associates first reported a position in Wright Medical Group, Inc. Contingent Value Right in Q4 2015 and held it in 12 quarters.
T. Rowe Price Associates's Wright Medical Group, Inc. Contingent Value Right position peaked at $208K in Q3 2017.
19 funds tracked by Wall St. Rank held Wright Medical Group, Inc. Contingent Value Right as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.